Clinical assessment of HRD scoring in relation to PARPi response in terms of statistical guidance on reporting results for CDx tests evaluation.

Bişgin, AtılBoğa, İbrahimEskut, Kaan İhsanRencüzoğulları, ÇağlaSönmezler, ÖzgeKöse, FatihBeşen, Ali AyberkÖlmez, Ömer FatihDişel, UmutKoçer, Nazım EmrahBolat, FilizJinga, Dan-CorneliuLazar, IoanaPathak, Surajit2024-01-112024-01-112023Bişgin, A., Boğa, İ., Eskut, K. İ., Rencüzoğulları, Ç., Sönmezler, Ö., Köse, F. ... Pathak, S. (2023). Clinical assessment of HRD scoring in relation to PARPi response in terms of statistical guidance on reporting results for CDx tests evaluation. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). Chicago, IL, 02-06 June, 2023.0732-183X1527-7755https://hdl.handle.net/20.500.12511/12122[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessCDx Tests EvaluationReporting ResultsHRD ScoringStatistical GuidanceClinical assessment of HRD scoring in relation to PARPi response in terms of statistical guidance on reporting results for CDx tests evaluation.Conference Object4116Q1001053772003977